• OTC Inhibition, Ornithine Accumulation, and Astrocyte Energy

  2026-07-21

  This study elucidates how realgar-derived arsenic impairs the liver–brain axis by inhibiting hepatic ornithine transcarbamylase (OTC), leading to ornithine accumulation and ZBTB7A-mediated repression of astrocyte glycolysis. The findings reveal a new mechanistic link between disrupted urea cycle function and central nervous system energy deficits, providing novel targets for neurotoxicity intervention.

• Dimetridazole Potentiates Cefotaxime Against MDR E. coli via

  2026-07-20

  This study reveals that dimetridazole, a 1,2-dimethyl-5-nitroimidazole compound, significantly enhances the antibacterial activity of cefotaxime against multidrug-resistant Escherichia coli by targeting bacterial membrane integrity and fatty acid biosynthesis. The findings highlight a promising combination strategy for overcoming antibiotic resistance, with implications for both mechanistic research and translational antimicrobial applications.

• BGJ398 (NVP-BGJ398): Optimizing FGFR-Driven Oncology Researc

  2026-07-20

  BGJ398 (NVP-BGJ398) offers bench scientists a highly selective tool to dissect FGFR signaling and drive apoptosis induction in cancer cells. This article decodes advanced protocol strategies, troubleshooting insights, and translational advantages, empowering oncology research teams to deliver reproducible, high-impact data.

• Cy5 NHS ester(Et): Protocols and Workflow for Protein Labeli

  2026-07-19

  Cy5 NHS ester(Et) enables precise, water-soluble fluorescent labeling of primary amines in proteins and biomolecules, supporting detection and imaging workflows such as immunofluorescence staining and flow cytometry. It is unsuitable for ethanol-based protocols or long-term storage of dye solutions, requiring researchers to follow strict dissolution and handling guidelines for consistent results.

• Rotavirus-Induced Suppression of Nrf2 Antioxidant Defense Me

  2026-07-18

  Patra et al. provide a mechanistic analysis showing that progressive rotavirus infection suppresses the redox-sensitive transcription factor Nrf2 and its downstream antioxidant gene expression in host cells. These findings clarify how viral infections can subvert cellular redox balance, informing targeted approaches for oxidative stress research and the development of redox-modulating interventions.

• EZ Cap™ mCherry mRNA: Red Fluorescent Protein mRNA for Preci

  2026-07-17

  Explore how EZ Cap™ mCherry mRNA unlocks advanced red fluorescent protein mRNA applications in high-fidelity reporter gene assays and dynamic redox biosensing. Go beyond standard protocols with mechanistic insights and practical strategies for robust, immune-evasive expression.

• Lactate-GPR81/FARP1 Axis Enables Insulin-Independent Glucose

  2026-07-17

  The reference study uncovers a lactate-driven signaling pathway—GPR81/FARP1—that facilitates glucose uptake in skeletal muscle without insulin, offering a mechanistic basis for exercise-induced glycemic control. These findings reveal new therapeutic targets for metabolic diseases and provide a platform for further investigation of insulin-independent glucose regulation.

• Amplifying Discovery: Cy3 TSA Fluorescence in Translational

  2026-07-16

  Explore how the Cy3 TSA Fluorescence System Kit from APExBIO transforms the detection of low-abundance biomolecules in liver cancer research and beyond. This thought-leadership article integrates mechanistic insight, evidence from landmark regulatory studies, and strategic guidance for translational scientists navigating the challenges of spatial and molecular resolution in complex tissue environments.

• Mubritinib–HSA Binding: Mechanisms and Pharmacological Impac

  2026-07-16

  This study elucidates how mubritinib, a mitochondrial complex I inhibitor, binds to human serum albumin (HSA) using multispectroscopic and molecular docking approaches. The findings clarify the nature, affinity, and functional consequences of the interaction, providing critical insight for optimizing the pharmacokinetics and efficacy of protein-bound therapeutics in cancer and metabolic disease research.

• Protoporphyrin IX (SKU B8225): Reliable Solutions for Cell A

  2026-07-15

  This article delivers a scenario-driven, evidence-based guide for researchers using Protoporphyrin IX (SKU B8225) in cell viability, proliferation, and ferroptosis assays. Drawing on validated protocols and peer-reviewed studies, it addresses workflow challenges and highlights the reproducibility, purity, and versatility of Protoporphyrin IX from APExBIO.

• Aztreonam Applications: Monocyclic β-Lactam Antibiotic in Re

  2026-07-15

  Aztreonam’s unique monocyclic β-lactam structure enables targeted inhibition of Gram-negative aerobic bacteria, making it invaluable for experimental workflows investigating resistance, metabolic impact, and cell biology. This article translates recent epidemiological findings into actionable protocols, troubleshooting strategies, and cross-study insights using APExBIO’s research-grade Aztreonam.

• ATM Inhibition Promotes Macropinocytosis and Metabolic Adapt

  2026-07-14

  The referenced study reveals that inhibition of ATM kinase drives cancer cell survival under nutrient stress through enhanced macropinocytosis. This finding uncovers a new metabolic vulnerability that may inform the design of combination therapies targeting both ATM and nutrient scavenging pathways.

• Scenario-Based Solutions with DiscoveryProbe™ FDA-approved D

  2026-07-14

  This article provides scenario-driven, evidence-based guidance for optimizing cell viability, proliferation, and cytotoxicity workflows using the DiscoveryProbe™ FDA-approved Drug Library (SKU: L1021). Designed for biomedical researchers, it addresses common laboratory challenges and demonstrates how SKU L1021 accelerates drug repositioning, improves reproducibility, and enhances high-throughput screening reliability.

• Low-Dose Chlorhexidine Disrupts E. faecalis Biofilms In Vitr

  2026-07-13

  Sebbane et al. provide a detailed mechanistic analysis of how low concentrations of chlorhexidine impair Enterococcus faecalis viability and biofilm integrity. The study leverages advanced imaging and molecular assays to reveal membrane disruption and gene regulation effects, offering actionable insights for refining endodontic disinfection protocols.

• Genomic Instability Drives Therapy Heterogeneity in CRC Meta

  2026-07-13

  Cho et al. present a comprehensive analysis of how dynamic genomic and transcriptomic changes during colorectal cancer (CRC) metastasis contribute to treatment heterogeneity. By integrating patient-derived xenograft models with multi-omics profiling, the study uncovers subclonal evolution as a key driver of drug resistance, offering critical insights for preclinical modeling and therapeutic strategy development.

455 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page